switching glp 1 agonists Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance Top GLP-1 Agonists Balance Weight
Description
doi: 10.1186/s40478-021-01180-z
17 Similarly, in a meta-analysis of 14 RCTs in T2DM patients conducted by Liu et al, tirzepatide was shown to provide superior HbA1c reduction and improved metabolic outcomes compared to placebo, insulin, and all other GLP-1 RAs at all doses examined
In kidney transplants, a slower decline in glomerular filtration rate, which measures kidney function, has been observed compared to other diabetes treatments
Second-line treatments include basal insulin, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RA), sodiumglucose cotransporter 2 inhibitors (SGLT2-I), sulfonylureas (SU), or thiazolidinediones (TZD)
[DOI] [PubMed] [Google Scholar] 61.Buteau J, Foisy S, Rhodes CJ, et al
TT-OAD2 is another small molecule that also exhibits biased agonism in a unique binding mode [46]
